Acutaas Chemicals is trading 4.49% up at ₹3,963.60, extending its rally following the October 27 Q2 FY27 results. - Revenue grew 42.7% year over year, net profit 71.4%, and EBITDA 84.6%. - Management raised its FY27 revenue-growth outlook to around 30% and EBITDA-margin guidance to 38–40%. - The stock gained 13.27% on October 27, followed by a further 4.49% move on October 28.